Intravenous immunoglobulin (IVIg) ameliorates disease in a murine model of anti-laminin 332 mucous membrane pemphigoid

Sripriya Murthy,Sabrina Patzelt,Axel Künstner,Hauke Busch,Enno Schmidt,Christian D. Sadik
DOI: https://doi.org/10.1016/j.jid.2024.02.038
IF: 7.59
2024-05-02
Journal of Investigative Dermatology
Abstract:Intravenous immunoglobulin (IVIg) is used to treat mucous membrane pemphigoid (MMP), although its therapeutic effectivity is not sufficiently supported by randomized controlled clinical trials and its mode of action is only insufficiently understood. We have examined the effect of IVIg in a mouse model of anti-laminin 332 MMP and found that IVIg ameliorates both cutaneous and mucosal inflammatory lesions. Our investigation into the modes of action of IVIg in MMP indicated effective...
dermatology
What problem does this paper attempt to address?